We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Midatech Pharma Plc | MTPH | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 18.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 18.00 | 18.00 |
| Top Posts |
|---|
Posted at 20/12/2022 08:27 by babbler Presentation today at 2pm to proper investors. |
Posted at 18/9/2022 19:03 by criticalthinker1 I'm reading more into this re Parker and his links to obviously sareum but also fidelity management galapagos GSK and physiomics...and a Belgian hnwi investor in sareumWheels within wheels. I continue with the digging |
Posted at 07/6/2022 12:28 by dave4545 No investors in this game now, almost 100% day traders looking for a fast buck so they all piled in and then the thought of having to hold is impossibleTraders would rather take a £5-10k loss in a day then hold the stock a few months and get their money back or a profit. But the RNS did say they are looking to recruit for a phase 1 so I never understood why it spiked so much, like I said there's Bio's well into phase 11 or 111 trials than have little or no support in this market so that rise was never going to last |
Posted at 27/5/2022 14:51 by kingston78 Looking at the share chart it amazed me to see the price spiked from 20 p to 86 p in August 2020. The price has 40 p since as its ceiling, drifting to the current 10 p level. Investors have treated this company too harshly. |
Posted at 27/5/2022 14:24 by ssrmb Kingston, on their website under Investors and share price info. |
Posted at 07/1/2022 20:59 by chique Canter Fitzgerald acquire 5% Iin MidatechFrom Canter Fitzgerald website US Healthcare Equities A particular strength is our US healthcare equities team. CFE’s rated analysts have deep specialization in their respective areas. Together they span almost the entirety of the US healthcare sector and cover the full range of market capitalization. Our research capabilities are complimented by regular expert calls in both the healthcare and tech sectors. We also provide a variety of corporate access opportunities for investors. |
Posted at 06/12/2021 09:39 by hisse been reading here, LSE and stocktwits for a while.Become obvious, in the lack of solid news, that group of so-called grid-players trading in london and new york hxxps://stocktwits.c aiming (with their wording " manipulate ") to take the midatech ADRS under $1 for company to be issued nasdaq notification then forcing the company to do another 1:5 reverse-split (consolidation). Company did it in the past Delayed news (blamed on covid if true) and Stamp attending investor webinars, while repeatedly stressed that company got money till Q1 2023, is playing into hands of grid-players, short attack and warrant holders. This will go under a dollar $1 in US in absence of a promised solid news and dispute with the secura bio not resolved is a worry as well for mtx110 Even though company is slimmer with a pipeline plus already achieved, credibility of Stamp (2 years now being CEO&CFO)and company are eroding fast, this is becoming more toxic Chart above shows the health of the company. all IMHO DYOR |
Posted at 24/11/2021 14:33 by melloteam Just to let shareholders and prospective investors know that Smiths News plc, Midatech Pharma plc, Jupiter Green Investment Trust, Wentworth Resources plc and Appreciate Group plc will be presenting at the Mello webinar event on Monday 13th December at 5:00pm. There will be over 500 investors attending and these are very popular shows with company presentations, fund manager and investor interviews, and panel sessions.Tickets are still available and if you would like one at half price then enter the code MMTADVFN50. |
Posted at 24/11/2021 07:34 by david gruen Midatech Pharma PLC24 November 2021 REACH 24 November 2021 Midatech Pharma PLC ("Midatech" or the "Company") Midatech presenting at the Shares and AJ Bell Webinar Midatech Pharma PLC (AIM: MTPH; Nasdaq: MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce that the Company's CEO and CFO, Stephen Stamp, will be presenting at the Shares and AJ Bell investor webinar on Wednesday 1 December 2021 at approximately 19.20 GMT. The Shares and AJ Bell evening webinars are an opportunity for senior board directors from quoted companies to make a presentation about their company and update existing and potential investors on their business plans. Shareholders and potential investors can register to join the webinar for free at: hxxps://www.sharesma |
Posted at 07/11/2021 22:37 by sharesoc Midatech shareholders and potential investors may be interested in our webinar on the 18th Nov. Stephen Stamp (CEO & CFO) will be presenting: |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
